Mental Health Clinics in Gulfport, FL Accepting Medicare
3 Mental Health Clinics found. Showing 1 - 3
 New Vision Behavioral Health Inc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1601 49th St S, Gulfport, FL 33707 Phone: 727-687-0997 |
Center For Human Potential, P.a. Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 5301 Gulfport Blvd S, Gulfport, FL 33707 Phone: 727-894-9777 Fax: 727-202-1010 |
Dr. Katie Schubert, Llc Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 6132 8th Ave S, Gulfport, FL 33707 Phone: 209-482-8567 |
News Archive
Nanotechnology approaches to solve major problems on global scale: Report
Nanotechnology refers to a broad range of tools, techniques and applications that simply involve particles on the approximate size scale of a few to hundreds of nanometers in diameter. Particles of this size have some unique physicochemical and surface properties that lend themselves to novel uses. Indeed, advocates of nanotechnology suggest that this area of research could contribute to solutions for some of the major problems we face on the global scale such as ensuring a supply of safe drinking water for a growing population, as well as addressing issues in medicine, energy, and agriculture.
The Bioethics of AI in the Healthcare Industry
With the advent of artificial intelligence, it is imperative that we examine the ethics of machine learning and data collection. Hugh Whittall, Director of the Nuffield Council on Bioethics, explains what AI is, how it is transforming the healthcare industry and the ethical concerns of the Council.
Newborn screening website to support quality health care for children
The National Library of Medicine (NLM) today launched the Newborn Screening Coding and Terminology Guide (http://newbornscreeningcodes.nlm.nih.gov), an important step toward efficient electronic exchange of standard newborn screening data.
Investigational treatment for ulcerative colitis (UC) and Crohn's disease (CD) has Marketing Authorisation Application submitted
Takeda Pharmaceutical Company Limited ("Takeda") today announced that a Marketing Authorisation Application (MAA) has been submitted to The European Medicines Agency (EMA) for vedolizumab, an investigational, gut-selective humanized monoclonal antibody for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD), the two most common types of inflammatory bowel disease (IBD).
› Verified 7 days ago